Verastem Has Strong Points, But The Long-Term Case Is Not Compelling

 

Verastem Has Strong Points, But The Long-Term Case Is Not Compelling

True, the CAR-T market leaders still have serious problems as well, including cost and safety issues, but the next generation of CAR-T will hopefully address these issues, and investing in those …

More Verastem Has Strong Points, But The Long-Term Case Is Not Compelling Videos

Leave a Reply